Perceptive Advisors Raised By $16.47 Million Its Tesaro (TSRO) Holding; Asure Software (ASUR)’s Sentiment Is 3.5

November 8, 2017 - By Henry Gaston

Perceptive Advisors Llc increased Tesaro Inc (TSRO) stake by 49.17% reported in 2017Q2 SEC filing. Perceptive Advisors Llc acquired 118,523 shares as Tesaro Inc (TSRO)’s stock declined 19.97%. The Perceptive Advisors Llc holds 359,551 shares with $50.29M value, up from 241,028 last quarter. Tesaro Inc now has $6.07 billion valuation. The stock declined 6.11% or $6.85 reaching $105.23 on the news. About 6,581 shares traded. TESARO Inc (NASDAQ:TSRO) has risen 254.28% since November 8, 2016 and is uptrending. It has outperformed by 237.58% the S&P500.

Asure Software, Inc. is a global provider of cloud software-as-a-service solutions that help companies to bring people, time, space and assets together. The company has market cap of $136.51 million. The Firm serves approximately 6,000 clients in over 80 countries. It currently has negative earnings. The Firm offers a range of solutions to help its clients optimize and manage mobile workforces and global workspaces.

Venator Capital Management Ltd. holds 5.08% of its portfolio in Asure Software Inc for 329,264 shares. Pacific Ridge Capital Partners Llc owns 377,917 shares or 1.62% of their US portfolio. Moreover, G2 Investment Partners Management Llc has 1.45% invested in the company for 224,068 shares. The Illinois-based Bard Associates Inc has invested 0.82% in the stock. Timpani Capital Management Llc, a Wisconsin-based fund reported 142,622 shares.

It closed at $10.99 lastly. It is down 137.62% since November 8, 2016 and is uptrending. It has outperformed by 120.92% the S&P500.

Ratings analysis reveals 100% of Asure Software’s analysts are positive. Out of 3 Wall Street analysts rating Asure Software, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $10.0 while the high is $12.0. The stock’s average target of $10.67 is -2.91% below today’s ($10.99) share price. ASUR was included in 3 notes of analysts from October 17, 2016. The firm has “Outperform” rating by Barrington Research given on Tuesday, November 1. Lake Street initiated Asure Software Inc (NASDAQ:ASUR) rating on Monday, October 17. Lake Street has “Buy” rating and $10.0 target. The stock has “Buy” rating by Wunderlich on Friday, October 28.

Analysts await Asure Software Inc (NASDAQ:ASUR) to report earnings on November, 13. They expect $0.14 EPS, up 40.00% or $0.04 from last year’s $0.1 per share. ASUR’s profit will be $1.74M for 19.63 P/E if the $0.14 EPS becomes a reality. After $0.05 actual EPS reported by Asure Software Inc for the previous quarter, Wall Street now forecasts 180.00% EPS growth.

Since June 6, 2017, it had 0 insider purchases, and 1 sale for $1.18 million activity. $1.18 million worth of TESARO Inc (NASDAQ:TSRO) was sold by English Edward C on Tuesday, June 6.

Among 24 analysts covering Tesaro Inc (NASDAQ:TSRO), 12 have Buy rating, 1 Sell and 11 Hold. Therefore 50% are positive. Tesaro Inc had 59 analyst reports since August 24, 2015 according to SRatingsIntel. Bank of America initiated TESARO Inc (NASDAQ:TSRO) rating on Tuesday, August 30. Bank of America has “Neutral” rating and $97 target. Wedbush initiated the shares of TSRO in report on Thursday, January 21 with “Outperform” rating. As per Friday, August 12, the company rating was initiated by RBC Capital Markets. The stock has “Buy” rating by Oppenheimer on Sunday, June 4. FBR Capital maintained TESARO Inc (NASDAQ:TSRO) rating on Monday, October 10. FBR Capital has “Outperform” rating and $115 target. The rating was downgraded by Leerink Swann to “Mkt Perform” on Friday, February 10. The stock has “Hold” rating by Piper Jaffray on Monday, October 23. Wells Fargo initiated the shares of TSRO in report on Friday, December 4 with “Outperform” rating. The firm has “Outperform” rating by RBC Capital Markets given on Monday, October 10. The rating was maintained by Cowen & Co on Wednesday, September 6 with “Hold”.

Perceptive Advisors Llc decreased Cidara Therapeutics Inc stake by 764,259 shares to 62,110 valued at $465,000 in 2017Q2. It also reduced Clearside Biomedical Inc stake by 91,881 shares and now owns 620,181 shares. Myokardia Inc was reduced too.